Nucleotide metabolic mismatches in mammalian hearts: Implications for transplantation

Annals of the Royal College of Surgeons of England

Volumn 95, Issue 1, 2013, Pages 9-14

  Khalpey, Z ^a   Yacoub, M H ^b   Smolenski, R T ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

5; Adenosine; Ecto; Nucleotidase; Xenotransplantation

Indexed keywords

5' NUCLEOTIDASE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL; ARTICLE; BABOON; BLOOD; CELL CULTURE; ENDOTHELIUM CELL; ENZYMOLOGY; GRAFT SURVIVAL; HEART MUSCLE; HUMAN; HUMORAL IMMUNITY; METABOLISM; PHYSIOLOGY; RAT; SPECIES DIFFERENCE; SWINE; TRANSGENIC ANIMAL; VASCULAR ENDOTHELIUM; XENOGRAFT;

5'-NUCLEOTIDASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GRAFT SURVIVAL; HUMANS; IMMUNITY, HUMORAL; MYOCARDIUM; PAPIO; PURINES; PYRIMIDINES; RATS; SPECIES SPECIFICITY; SUS SCROFA; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84872125138     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588413X13511609955571     Document Type: Article

References (37)

1. Khalpey Z, Yuen AH, Kalsi KK et al. Loss of ecto-5'nucleotidase from porcine endothelial cells after exposure to human blood: implications for xenotransplantation. Biochim Biophys Acta 2005; 1, 741: 191-198.
2. Feng S. Donor intervention and organ preservation: where is the science and what are the obstacles. Am J Transplant 2010; 10: 1,155-1,162.
3. Cooper DK, Ayares D. The immense potential of xenotransplantation in surgery. Int J Surg 2011; 9: 122-129.
4. Smolenski RT, Khalpey Z, Osborne FN et al. Species differences of endothelial extracellular nucleotide metabolism and its implications for xenotransplantation. Pharmacol Rep 2006; 58 Suppl: 118-125.
5. Schmelzle M, Schulte Esch J, Robson SC. Coagulation, platelet activation and thrombosis in xenotransplantation. Curr Opin Organ Transplant 2010; 15: 212-218.
6. Ghebremariam YT, Smith SA, Anderson JB et al. Intervention strategies and agents mediating the prevention of xenorejection. Ann N Y Acad Sci 2005; 1,056: 123-143.
7. Li S, Waer M, Billiau AD. Xenotransplantation: role of natural immunity. Transpl Immunol 2009; 21: 70-74.
8. Cooper DK, Good AH, Koren E et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1: 198-205.
9. Adelstein RS, Conti MA, Hathaway DR, Klee CB. Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine 3': 5'-monophosphate-dependent protein kinase. J Biol Chem 1978; 253: 8,347-8,350.
10. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964-966.
11. Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complementmediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 1991; 52: 530-533.
12. McCurry KR, Kooyman DL, Diamond LE et al. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs. Transplant Proc 1995; 27: 317-318.
13. Bhatti FN, Schmoeckel M, Zaidi A et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc 1999; 31: 958.
14. Ramirez P, Chavez R, Majado M et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70: 989-998.
15. Loss M, Przemeck M, Schmidtko J et al. Long-term survival of cynomolgus monkeys following pig-to-primate kidney xenotransplantation using h-DAF transgenic donor organs. Transplant Proc 2000; 32: 1,095-1,096.
16. Vial CM, Ostlie DJ, Bhatti FN et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000; 19: 224-229.
17. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11: 29-31.
18. Tseng YL, Kuwaki K, Dor FJ et al. alpha1,3-Galactosyltransferase geneknockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1,493-1,500.
19. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11: 32-34.
20. Weiss MJ, Ng CY, Madsen JC. Tolerance, xenotransplantation: future therapies. Surg Clin North Am 2006; 86: 1,277-1,296, viii.
21. Khalpey Z, Yuen AH, Lavitrano M et al. Mammalian mismatches in nucleotide metabolism: implications for xenotransplantation. Mol Cell Biochem 2007; 304: 109-117.
22. Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004; 113: 1,440-1,446.
23. Robson SC, Wu Y, Sun X et al. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 2005; 31: 217-233.
24. Khalpey Z, Koch CA, Platt JL. Xenograft transplantation. Anesthesiol Clin North America 2004; 22: 871-885.
25. Robson SC, Schulte am Esch J, Bach FH. Factors in xenograft rejection. Ann N Y Acad Sci 1999; 875: 261-276.
26. Spitsin S, Hooper DC, Mikheeva T, Koprowski H. Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins. Mult Scler 2001; 7: 165-166.
27. Kalsi KK, Zych M, Slominska EM et al. Adenine incorporation in human and rat endothelium. Biochim Biophys Acta 1999; 1,452: 145-150.
28. Smolenski R, Kochan Z, Karbowska J et al. Low expression of ecto-5'-nucleotidase in the pig heart - a potential barrier to xenotransplantation. J Heart Lung Transplant 2001; 20: 214-215.
29. Smolenski RT, Forni M, Maccherini M et al. Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs. Cardiovasc Res 2007; 73: 143-152.
30. Bravery CA, Batten P, Yacoub MH, Rose ML. Direct recognition of SLA- and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2. Transplantation 1995; 60: 1,024-1,033.
31. Osborne FN, Kalsi KK, Lawson C et al. Expression of human ecto-5'-nucleotidase in pig endothelium increases adenosine production and protects from NK cell-mediated lysis. Am J Transplant 2005; 5: 1,248-1,255.
32. Kochan Z, Smolenski RT, Yacoub MH, Seymour AL. Nucleotide and adenosine metabolism in different cell types of human and rat heart. J Mol Cell Cardiol 1994; 26: 1,497-1,503.
33. Smolenski RT, Lachno DR, Ledingham SJ, Yacoub MH. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 1990; 527: 414-420.
34. Khalpey Z, Kalsi K, Yuen A et al. Exposure to human blood inactivates swine endothelial ecto-5'-nucleotidase. Nucleosides Nucleotides Nucleic Acids 2005; 24: 271-274.
35. Wilson AC, Cahn RD, Kaplan NO. Functions of the two forms of lactic dehydrogenase in the breast muscle of birds. Nature 1963; 197: 331-334.
36. Smolenski RT, Raisky O, Slominska EM et al. Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply. Circulation 2001; 104: I246-I252.
37. Smolenski RT, Raisky O, Zych M et al. Enhanced endogenous adenosine protects from reperfusion injury after heart transplantation. Transplant Proc 2001; 33: 924-925.